SAN DIEGO & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx® Corp. today announced positive one-year results from the U.S. LIBERATE pivotal trial of the Zephyr® Endobronchial Valve, a ...
GRAND RAPIDS, MI – A new medical device, approved by the FDA in 2018, is helping American’s with COPD and Emphyzema, live a better, healthier life. Symptoms of Emphysema include fatigue chronic ...
The Zephyr valve is a device that can improve breathing in people with emphysema, one of the two most common types of chronic obstructive pulmonary disease (COPD). The valve received approval by the ...
Hosted on MSN
What are Zephyr Valves? Groundbreaking COPD treatment brings hope to Panhandle patients
Chronic Obstructive Pulmonary Disease (COPD) and emphysema are debilitating conditions that can make even simple tasks like walking or climbing stairs feel insurmountable. For many in the Texas ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced the publication of long ...
Spectrum Health is one of the first hospitals in Michigan to offer a novel treatment for emphysema. The treatment uses the Zephyr® Valve system, an FDA-approved minimally invasive procedure requiring ...
The Zephyr Endobronchial Valve has been given market approval by the Food and Drug Administration. The treatment is for those with severe emphysema, which is a type of chronic obstructive pulmonary ...
The US Food and Drug Administration (FDA) has approved the Zephyr Endobronchial Valve (Pulmonx Corp) to treat breathing difficulty associated with severe emphysema. "Treatment options are limited for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback